Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress

Go back to Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress
Kirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) Delayed: 17.45 +0.07 (0.40%)
Previous Close $17.38    52 Week High $18.64 
Open $17.53    52 Week Low $12.59 
Day High $17.57    P/E N/A 
Day Low $17.42    EPS $0.00 
Volume 35,008       

(NASDAQ: KURA) Delayed: 10.36 +0.43 (4.33%)
Previous Close $9.93    52 Week High $8.90 
Open $9.96    52 Week Low $2.50 
Day High $10.54    P/E N/A 
Day Low $9.95    EPS $0.00 
Volume 1,383,616       

(AMEX: KYKOY) Delayed: 15.58 --0 (-0%)
Previous Close $15.58    52 Week High
Open $15.58    52 Week Low
Day High $15.58    P/E N/A 
Day Low $15.58    EPS
Volume 539